Evid Invest
Who owns PBLSWhat PBLS owns — n/a

Who owns Parabilis Medicines, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of PBLS from SEC Form 13F filings across 127 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 127 institutions disclosed 110.1M shares of Parabilis Medicines, Inc. worth $3.54B — about 89.1% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.

127

13F holders

$3.54B

value, 2026 filers

89.1%

of shares outstanding (110.1M sh)

59

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PBLS's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1RA CAPITAL MANAGEMENT, L.P.29.2M$942.2M9.5%23.6%+0.8%
2FMR LLC10.9M$336.6M0.0%8.8%+5.6%
3ARCH Venture Management, LLC6.4M$207.1M12.8%5.2%0.0%
4venBio Partners LLC5.3M$170.1M34.3%4.3%0.0%
5Alphabet Inc.4.9M$158.9M0.2%4%0.0%
6Nextech Invest Ltd.4.7M$150.6M6.7%3.8%0.0%
7Cormorant Asset Management, LP4.6M$149.0M10.0%3.7%0.0%
8REGENERON PHARMACEUTICALS, INC.4.2M$134.5M74.9%3.4%0.0%
9Janus Henderson Group Ltd.NEW3.3M$105.8M0.0%2.7%new
10Siren, L.L.C.3.0M$96.6M2.3%2.4%0.0%
11BlackRock, Inc.NEW2.8M$90.1M0.0%2.3%new
12FARALLON CAPITAL MANAGEMENT, L.L.C.2.4M$76.5M0.3%1.9%0.0%
13Frazier Life Sciences Management, L.P.2.3M$75.3M1.9%1.9%+21.3%
14DEERFIELD MANAGEMENT COMPANY, L.P.1.9M$60.7M0.9%1.5%0.0%
15Soleus Capital Management, L.P.1.7M$54.4M1.9%1.4%+15.0%
16General Catalyst Group Management, LLC1.6M$51.7M10.8%1.3%0.0%
17VANGUARD PORTFOLIO MANAGEMENT LLC1.6M$51.1M0.0%1.3%+21.5%
18VANGUARD CAPITAL MANAGEMENT LLC1.6M$50.3M0.0%1.3%+34.5%
19GENERAL ATLANTIC, L.P.1.5M$49.7M2.0%1.2%0.0%
20JPMORGAN CHASE & CO1.1M$33.9M0.0%0.9%+1.9%
21GEODE CAPITAL MANAGEMENT, LLC1.0M$32.5M0.0%0.8%+911.4%
22Foresite Capital Management VI LLC999,044$32.3M5.7%0.8%0.0%
23Catalio Capital Management, LP824,043$26.6M4.9%0.7%0.0%
24PRICE T ROWE ASSOCIATES INC /MD/766,727$24.8M0.0%0.6%+2.0%
25ALLIANCEBERNSTEIN L.P.765,186$24.7M0.0%0.6%-5.6%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.